Lactoferrin inhibits human papillomavirus binding and uptake in vitro.
2004 (English)In: Antiviral Research, ISSN 0166-3542, E-ISSN 1872-9096, Vol. 64, no 1, 63-68 p.Article in journal (Refereed) Published
Lactoferrin (LF), a member of the transferrin family, is a bi-globular protein secreted in milk, saliva, tears, seminal fluid, endocervix and vaginal secretions. LF is an important player in the defence against pathogenic microorganisms and has also been shown to have activity against several viruses including herpesvirus, adenovirus, rotavirus and poliovirus. The antiviral activity of LF is directed against the early steps of viral infection and the LF antiviral effect against herpesvirus is mediated through LF binding to the herpesvirus receptor heparan sulfate. Human papillomavirus (HPV) causes genital warts and is a prerequisite for cervical cancer. HPV can also use heparan sulfate on the cell surface as a receptor. We studied the inhibition by LF on HPV entry by incubating HaCaT cells and HPV-16 virus-like particles (VLPs) with either human (HLF) or bovine lactoferrin (BLF). LF inhibited internalization of HPV-16 particles using CFDA-SE-labelled VLPs that only fluoresce after internalisation. By using a western blot assay we also found dose-dependent LF inhibition of HPV-16 VLP binding to the HaCaT cell surface. BLF was a more potent inhibitor of HPV entry than human LF. It was also clear that LF acted early in the HPV uptake process.
Place, publisher, year, edition, pages
2004. Vol. 64, no 1, 63-68 p.
Lactoferrin, Human papillomavirus, Heparan sulfate, Antiviral activity
IdentifiersURN: urn:nbn:se:umu:diva-20707DOI: 10.1016/j.antiviral.2004.05.005PubMedID: 15451180OAI: oai:DiVA.org:umu-20707DiVA: diva2:209377